SBBP - Strongbridge Biopharma plc's (SBBP) CEO John Johnson on Q4 2020 Results - Earnings Call Transcript
Strongbridge Biopharma plc (SBBP) Q4 2020 Earnings Conference Call March 03, 2021, 08:30 AM ET Company Participants Lindsay Rocco - Elixir Health, Public Relations John Johnson - Chief Executive Officer Fredric Cohen - Chief Medical Officer Richard Kollender - Chief Financial Officer and Chief Operating Officer Scott Wilhoit - Chief Commercial Officer Conference Call Participants Chris Howerton - Jefferies Hartaj Singh - Oppenheimer & Company Annabel Samimy - Stifel Jonathan Wolleben - JMP Securities Robin Garner - Craig-Hallum Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Strongbridge Biopharma Plc Corporate Update and Fourth Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your host,
For further details see:
Strongbridge Biopharma plc's (SBBP) CEO John Johnson on Q4 2020 Results - Earnings Call Transcript